Search

Your search keyword '"Mok, T.S.K."' showing total 6 results
Start Over Author "Mok, T.S.K." Topic epidermal growth factor receptors
6 results on '"Mok, T.S.K."'

1. 585P Real-world outcomes in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations receiving mobocertinib.

Author

Mok, T.S.K., Liu, G., Nyaw, S.F., Curcio, H., Cortot, A., Kam, T.Y., Descourt, R., Chik, Y.K., Cheema, P.K., Gwinnutt, J.M., Churchill, E.N., Nyborn, J., Curran, E., Yin, Y., Chong, K., Tanaka-Chambers, Y., Kretz, J., and Cadranel, J.

Subjects
*NON-small-cell lung carcinoma, *INSERTION mutation, *EPIDERMAL growth factor receptors, *TREATMENT effectiveness
Published
2023
Full Text
View/download PDF

2. LBA8 Nivolumab (NIVO) + chemotherapy (chemo) vs chemo in patients (pts) with EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) with disease progression after EGFR tyrosine kinase inhibitors (TKIs) in CheckMate 722.

Author

Mok, T.S.K., Nakagawa, K., Park, K., Ohe, Y., Girard, N., Kim, H.R., Wu, Y-L., Gainor, J., Lee, S-H., Chiu, C-H., Sang-We, K., Cheng-Ta, Y., Liang, W., Wu, L., Lin, M-C., Samol, J., Zhang, X., Sylvester, J., Li, S., and Yang, J.C-H.

Subjects
*NON-small-cell lung carcinoma, *PROTEIN-tyrosine kinase inhibitors, *NIVOLUMAB, *DISEASE progression, *EPIDERMAL growth factor receptors
Published
2022
Full Text
View/download PDF

4. 507O EXCLAIM-2: Phase III trial of first-line (1L) mobocertinib versus platinum-based chemotherapy in patients (pts) with epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)+ locally advanced/metastatic NSCLC.

Author

Jänne, P.A., Wang, B-C., Cho, B.C., Zhao, J., Li, J., Hochmair, M.J., Peters, S., Besse, B., Kato, T., Wu, Y-L., Nguyen, D., Lin, J., Vranceanu, F., Lin, M., Fram, R.J., and Mok, T.S.K.

Subjects
*EPIDERMAL growth factor receptors, *CLINICAL trials, *NON-small-cell lung carcinoma, *CANCER chemotherapy, *METASTASIS
Published
2023
Full Text
View/download PDF

6. 362P Intracranial activity of dacomitinib in treatment naïve advanced EGFR mutated non-small cell lung cancer (NSCLC): Prespecified subgroup analysis of the ATORG-003 trial.

Author

Tan, A., Kim, D-W., Baisamut (Reungwetwattana), T., Yueh Ni, L., Ho, G.F., Tho, L.M., Prasongsook, N., Lee, S., Mok, T.S.K., Tan, D.S.W., and Loong, H.H.F.

Subjects
*NON-small-cell lung carcinoma, *EPIDERMAL growth factor receptors, *SUBGROUP analysis (Experimental design)
Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results